Clinical Trial Update: A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of ASKP1240 in de novo kidney transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• ASKP1240

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Kidney Transplantation | Phase 2 | Status: COMPLETED